ArticleJournal of virology2025
ASFV pE146L-induced ER remodeling is essential for viral replication.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Epigallocatechin gallate (EGCG) inhibits African swine fever virus replication by targeting key viral proteins and regulating host lipid metabolism.Emerging microbes & infections · 2026Article
- Loss of ribosomal protein RPL22 restricts African swine fever virus replication by inducing PERK-dependent ER stress.Emerging microbes & infections · 2026Article
- Identification of B-Cell Linear Epitopes on pE146L Protein of African Swine Fever Virus Using Monoclonal Antibodies.Microorganisms · 2026Article
- Article
- Host-pathogen interactions in African swine fever: From viral entry to systemic disease progression.Cell insight · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
African swine fever virus (ASFV) causes a severe hemorrhagic disease, posing a significant threat to the global pig industry. Although the ASFV encodes nearly 200 proteins, the functions of many remain unknown. Here, we identify the inner envelope protein pE146L as essential for ASFV replication. pE146L, localized in the endoplasmic reticulum lumen, induces endoplasmic reticulum (ER) perinuclear aggregation, and its absence disrupts viral factory formation. Mechanistic studies revealed the first high-resolution crystal structure of pE146L-ΔTM. Structural and biochemical analyses revealed that disrupting the intermolecular disulfide bonds of the dimers (C103A) abrogates ER aggregation and impedes viral replication. Furthermore, pE146L binds lipids via a positively charged surface patch, a function critical for replication, suggesting a role in lipid regulation. These findings highlight the multifunctionality of pE146L in ASFV morphogenesis and provide a promising target for anti-ASFV drug development. IMPORTANCE: African swine fever virus (ASFV) causes a highly lethal infectious disease in swine; however, our understanding of its replication and assembly mechanisms remains limited, which hinders the development of vaccines and drugs. In this study, we identified the uncharacterized pE146L, a protein of the inner envelope that is required for the viral life cycle. Notably, we found that pE146L showed distinct colocalization and the ability to induce noticeable ER aggregation. Moreover, we solved the first high-resolution crystal structure of the extracellular soluble region of pE146L and discovered that it is a lipid-binding protein. Interestingly, structural and biochemical analyses suggest the potentially significant impact of intermolecular disulfide bonds on ER aggregation and viral replication. These results highlight the multifunctionality of ASFV pE146L, providing new insights for the development of specific antiviral drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.